bexarotene

FDA Drug Profile — Targretin, bexarotene

bexarotene is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including Targretin, bexarotene. Available dosage forms: gel, capsule, liquid filled.

Drug details

Generic Name
bexarotene
Brand Names
Targretin, bexarotene
Application Number
NDA021056
Sponsor
Bausch Health US, LLC
NDC Codes
6
Dosage Forms
GEL, CAPSULE, LIQUID FILLED
Routes
TOPICAL, ORAL
Active Ingredients
BEXAROTENE

Indications and Usage

1 INDICATIONS AND USAGE Bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. Bexarotene capsules are a retinoid indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.